REMEL INC.

REMEL INC. specializes in the manufacturing of in vitro diagnostic substances and analytical laboratory instrumentation, serving critical public health and veterinary research missions. The company produces microbiological culture media, antimicrobial susceptibility testing supplies, and compatible reagents for automated detection systems such as Sensititre, supporting infection diagnostics in clinical and research environments. Their technical expertise extends to precision equipment maintenance and calibration, particularly for laboratory instrumentation used in antimicrobial resistance surveillance and sterile body fluid analysis. REMEL’s unique value lies in its deep integration with federal reference labs, providing validated, traceable reagents and hardware that meet stringent regulatory and quality standards for pathogen detection and antimicrobial stewardship. The contractor maintains consistent, long-term relationships with the Department of Health and Human Services, where it supplies diagnostic materials for the CVM’s NARMS and VET-LIRN programs, and the Department of Veterans Affairs, providing microbiology testing systems and Sensititre ARIS maintenance services. The U.S. Department of Agriculture is another key partner, relying on REMEL for analytical instrumentation and AST supplies to support national animal health and food safety surveillance through ARS laboratories. REMEL’s primary industry focus is in in vitro diagnostic substance manufacturing (NAICS 325413) and analytical laboratory instrument manufacturing (NAICS 334516), positioning it as a niche supplier to federal public health and veterinary diagnostics networks. The company operates at the intersection of clinical microbiology and laboratory automation, serving agencies engaged in antimicrobial resistance monitoring, infectious disease surveillance, and laboratory quality assurance. REMEL INC. is a small business structured as a 2L entity headquartered in Lenexa, Kansas. While no federal certifications are listed, its consistent performance across high-sensitivity government contracts demonstrates reliability in regulated environments requiring compliance with clinical and laboratory standards. The company’s geographic presence and technical specialization make it a trusted provider within the federal life sciences and public health supply chain.